October 2019

ETAP-Lab will participate at MEDICA next 19 November in Dusseldorf. Our experts Dr. Jean-François BISSON (VP) and Dr. Nicolas Violle (CEO) will present ETAP-Lab’s services in the fields of preclinical Dermatology with our partner CYCERON.ETAP-Lab has a track-record of success in the testing of medical devices in the field of Dermatology, such as dressing, plaster and bandage.Please feel free to contact us if you want to schedule a one-to-one meeting. Looking forward to meeting with you. Contact us

ETAP-Lab will participate at Bio Europe next 11-13 November in Hamburg. Our experts Dr. Jean-François BISSON (VP) and Dr. Nicolas Violle (CEO) will present ETAP-Lab’s services in the fields of preclinical Dermatology and Central Nervous System. Please feel free to contact us if you want to schedule a one-to-one meeting. Looking forward to meeting with you.

Last June, we produced the 1st batch of beta-amyloid1-42 oligomers in our new facilities, using our unique know-how for oligomers production and stabilization (see here). We are very happy and proud to announce that we have now extensively validated the following in vitro pharmacological models: A model of Alzheimer’s disease: challenge with beta-Amyloid1-42 oligomers in rat primary cortical neuron culture; A model of Parkinson’s disease: challenge with alpha-synuclein oligomers in rat primary cortical neuron culture. Batch-to-batch oligomer production reproducibility has been controlled, confirming the